Showing results (161-170 of 172) with videos related to

Sort By:
Pageof 18
Cardiovascular Endocrinology & Metabolism|August 18, 2020
Obese communities among the best predictors of COVID-19-related deathsAntoine Fakhry AbdelMassih, Ramy Ghaly, Abeer Amin, et al.
Cardiovascular Endocrinology & Metabolism|August 18, 2020
Is it infection or rather vascular inflammation? Game-changer insights and recommendations from patterns of multi-organ involvement and affected subgroups in COVID-19Antoine Fakhry AbdelMassih, Aya Kamel, Fady Mishriky, et al.
Cardiovascular Endocrinology & Metabolism|October 20, 2025
Composite risk of cardiovascular disease comorbidity in people living with diabetes in AfricaRegina Idu Ejemot-Nwadiaro, Divine-Favour Chichenim Ofili, Stephen Chukwuma Ogbodo, et al.
Cardiovascular Endocrinology & Metabolism|July 15, 2025
The effect of oleoylethanolamide supplementation on cardiometabolic factors: a systematic review and meta-analysisMasoumeh Eslahi, Pejman Rohani, Somaye Fatahi, et al.
Cardiovascular Endocrinology & Metabolism|September 8, 2025
BRIDGE-DS study: evaluating the effectiveness and safety of dapagliflozin/sitagliptin combination in type 2 diabetes mellitus patients with heart failureKandanat Purushothaman Nair Suresh Kumar, Manikandan Thiruvanath Variam, Bala Vignesh S, et al.
Cardiovascular Endocrinology & Metabolism|October 30, 2024
Efficacy and safety of double-dose statin monotherapy versus moderate-intensity statin combined with ezetimibe dual therapy in diabetic patients: a systematic review and meta-analysis of randomized controlled trialsAman Goyal, Muhammad Daoud Tariq, Hritvik Jain, et al.
Cardiovascular Endocrinology & Metabolism|April 28, 2025
How does the addition of antiplatelet therapy to antithrombotic therapy in patients with atrial fibrillation and stable coronary artery disease affect outcomes? A meta-analysis of randomized controlled trialsAqsa Shoaib, Nikhil Duseja, Moeez Ibrahim Shiraz, et al.
Cardiovascular Endocrinology & Metabolism|March 7, 2025
Does dietary intake of vitamin A and beta-carotene increase the risk of hypertension?Sasan Rahmanian, Zahra Salimi, Mohammad Masoumvand, et al.
Cardiovascular Endocrinology & Metabolism|March 11, 2025
Pitavastatin-induced cholesterol deficiency elevates serum biomarkers associated with statin-related adverse effects in ratsSakhavat Abolhasani, Yasin Ahmadi, Hossein Mozafar Saadati
Cardiovascular Endocrinology & Metabolism|December 15, 2025
Genetic evidence for the causal relationship between metabolic diseases and primary aldosteronism: insights from Mendelian randomization analysisHuan Zhang, Zixin Lin, Wei Tian, et al.
Pageof 18